X-linked Adrenal Hypoplasia Congenita Market is expected to grow at a healthy CAGR during forecast period of 2022 to 2029
Introduction X-linked adrenal hypoplasia congenita (AHC) Market is a rare genetic disorder that affects the development and function of the adrenal glands. This condition is primarily caused by mutations in the NR0B1 gene located on the X chromosome. The disease is typically characterized by adrenal insufficiency, hypogonadotropic hypogonadism, and impaired sexual development, with symptoms often presenting in infancy or early childhood. Due to its rarity and complex clinical manifestations, AHC poses significant diagnostic and therapeutic challenges. As global awareness of rare diseases continues to rise, the healthcare industry has witnessed growing investment in the diagnosis and treatment of X-linked AHC. The market has experienced consistent development, with technological advancements in genetic testing, an expanding pipeline of therapies, and a more robust regulatory framework that encourages orphan drug development. This article explores the various dimensions of th...